Table 2 Sample characteristics (physiological variables) and prevalence of meeting physical activity recommendations
Sample characteristics | Total sample | Meeting physical activity recommendations | P-value |
|---|---|---|---|
n = 305(%) | n = 66 (21.6%) | ||
BMI (kg/m2) | Â | Â | 0.600 |
 Normal 18.5–24.99 | 34 (11) | 7 (21) |  |
 Overweight >25–29.99 | 118 (39) | 29 (25) |  |
 Obese >30 | 153 (50) | 30 (20) |  |
Current medication | Â | Â | Â |
 Blood pressure lowering | 217 (71) | 45 (21) | 0.500 |
 Lipid lowering | 189 (62) | 40 (21) | 0.800 |
 Oral-hypoglycaemic drugs | 260 (85) | 53 (20) | 0.200 |
 Insulin | 75 (25) | 12 (16) | 0.200 |
 Diet control | 45 (15) | 32 (71) | 0.200 |
Duration of diabetes (years) | Â | Â | 0.500 |
  < 5 | 140 (46) | 37 (26) |  |
 6 to 11 | 117 (38) | 18 (15) |  |
 12 to 18 | 33 (11) | 6 (18) |  |
  > 18 | 15 (5) | 5 (33) |  |
Blood pressure (systolic/diastolic) mmHg** | Â | Â | 0.500 |
 Within target (<140/<80) | 237 (78) | 49 (21) |  |
 High (≥140/≥80) | 68 (22) | 17 (25) |  |
HbA1c (%)** | Â | Â | 0.300 |
 Normal ≤7% | 127 (42) | 31 (24) |  |
 High >7% | 178 (58) | 35 (20) |  |
Fasting lipid profile (mmol/L)** | Â | Â | Â |
 Cholesterol Within target (< 5.0) | 201 (66) | 44 (22) | 0.900 |
 Cholesterol High (≥5.0) | 104 (34) | 22 (21) | |
 HDL Within target (>1.0) | 254 (83) | 58 (23) | 0.300 |
 HDL Less protective (≤1.0) | 51 (17) | 8 (16) | |
 LDL Within target (<2.6) | 188 (62) | 40 (21) | 0.800 |
 LDL High (≥2.6) | 117 (38) | 26 (22) | |
 TG Within target (<1.7) | 205 (67) | 42 (20) | 0.500 |
 TG High (≥1.7) | 100 (33) | 24 (24) | |
Comorbidities | Â | Â | 0.030* |
 Yes | 277 (91) | 55 (20) |  |
 No | 28 (9) | 11 (39) |  |